Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Marsha Anderson to Mucocutaneous Lymph Node Syndrome

This is a "connection" page, showing publications Marsha Anderson has written about Mucocutaneous Lymph Node Syndrome.

 
Connection Strength
 
 
 
2.506
 
  1. Dominguez SR, Anderson MS. Advances in the treatment of Kawasaki disease. Curr Opin Pediatr. 2013 Feb; 25(1):103-9.
    View in: PubMed
    Score: 0.358
  2. Anderson MS, Todd JK, Glodé MP. Delayed diagnosis of Kawasaki syndrome: an analysis of the problem. Pediatrics. 2005 Apr; 115(4):e428-33.
    View in: PubMed
    Score: 0.208
  3. Lam JY, Shimizu C, Gardiner MA, Giorgio T, Wright V, Baker A, Anderson MS, Heizer H, Mohandas S, Kazarians A, Kaneta K, Jone PN, Dominguez SR, Szmuszkovicz JR, Newburger JW, Tremoulet AH, Burns JC. External Validation of a Machine Learning Model to Diagnose Kawasaki Disease. J Pediatr. 2025 07; 282:114543.
    View in: PubMed
    Score: 0.207
  4. Anderson MS. Kawasaki-like illness in Human Immuno-deficiency Virus-infected patients: is the etiologic agent the same as in pediatric Kawasaki disease? Clin Infect Dis. 2002 Mar 15; 34(6):875-8.
    View in: PubMed
    Score: 0.168
  5. Jone PN, Korst A, Karimpour-Fard A, Thomas T, Dominguez SR, Heizer H, Anderson MS, Glode MP, Sucharov CC, Miyamoto SD. Circulating microRNAs differentiate Kawasaki Disease from infectious febrile illnesses in childhood. J Mol Cell Cardiol. 2020 09; 146:12-18.
    View in: PubMed
    Score: 0.150
  6. Hao S, Ling XB, Kanegaye JT, Bainto E, Dominguez SR, Heizer H, Jone PN, Anderson MS, Jaggi P, Baker A, Son MB, Newburger JW, Ashouri N, McElhinney DB, Burns JC, Whitin JC, Cohen HJ, Tremoulet AH. Multicentre validation of a computer-based tool for differentiation of acute Kawasaki disease from clinically similar febrile illnesses. Arch Dis Child. 2020 08; 105(8):772-777.
    View in: PubMed
    Score: 0.146
  7. Dominguez SR, Birkholz M, Anderson MS, Heizer H, Jone PN, Glode MP, Todd JK. Diagnostic and Treatment Trends in Children With Kawasaki Disease in the United States, 2006-2015. Pediatr Infect Dis J. 2019 10; 38(10):1010-1014.
    View in: PubMed
    Score: 0.142
  8. Tremoulet AH, Jain S, Jone PN, Best BM, Duxbury EH, Franco A, Printz B, Dominguez SR, Heizer H, Anderson MS, Glodé MP, He F, Padilla RL, Shimizu C, Bainto E, Pancheri J, Cohen HJ, Whitin JC, Burns JC. Phase I/IIa Trial of Atorvastatin in Patients with Acute Kawasaki Disease with Coronary Artery Aneurysm. J Pediatr. 2019 12; 215:107-117.e12.
    View in: PubMed
    Score: 0.142
  9. Jone PN, Anderson MS, Mulvahill MJ, Heizer H, Glodé MP, Dominguez SR. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective? Pediatr Infect Dis J. 2018 10; 37(10):976-980.
    View in: PubMed
    Score: 0.132
  10. Zeft AS, Burns JC, Yeung RS, McCrindle BW, Newburger JW, Dominguez SR, Anderson MS, Arrington C, Shulman ST, Yoon J, Tewelde H, Mix C, Pope CA. Kawasaki Disease and Exposure to Fine Particulate Air Pollution. J Pediatr. 2016 10; 177:179-183.e1.
    View in: PubMed
    Score: 0.114
  11. Turnier JL, Anderson MS, Heizer HR, Jone PN, Glodé MP, Dominguez SR. Concurrent Respiratory Viruses and Kawasaki Disease. Pediatrics. 2015 Sep; 136(3):e609-14.
    View in: PubMed
    Score: 0.107
  12. Phadke D, Patel SS, Dominguez SR, Heizer H, Anderson MS, Glode MP, Jone PN. Tissue Doppler Imaging as a Predictor of Immunoglobulin Resistance in Kawasaki Disease. Pediatr Cardiol. 2015 Dec; 36(8):1618-23.
    View in: PubMed
    Score: 0.105
  13. Dominguez SR, Martin B, Heizer H, Jone PN, Tong S, Davidson J, Anderson MS, Glodé MP. Procalcitonin (PCT) and Kawasaki Disease: Does PCT Correlate With IVIG-Resistant Disease, Admission to the Intensive Care Unit, or Development of Coronary Artery Lesions? J Pediatric Infect Dis Soc. 2016 Sep; 5(3):297-302.
    View in: PubMed
    Score: 0.104
  14. Eladawy M, Dominguez SR, Anderson MS, Glodé MP. Kawasaki disease and the pediatric gastroenterologist: a diagnostic challenge. J Pediatr Gastroenterol Nutr. 2013 Mar; 56(3):297-9.
    View in: PubMed
    Score: 0.090
  15. Dominguez SR, Anderson MS, El-Adawy M, Glodé MP. Preventing coronary artery abnormalities: a need for earlier diagnosis and treatment of Kawasaki disease. Pediatr Infect Dis J. 2012 Dec; 31(12):1217-20.
    View in: PubMed
    Score: 0.088
  16. Eladawy M, Dominguez SR, Anderson MS, Glodé MP. Abnormal liver panel in acute kawasaki disease. Pediatr Infect Dis J. 2011 Feb; 30(2):141-4.
    View in: PubMed
    Score: 0.078
  17. Dominguez SR, Friedman K, Seewald R, Anderson MS, Willis L, Glodé MP. Kawasaki disease in a pediatric intensive care unit: a case-control study. Pediatrics. 2008 Oct; 122(4):e786-90.
    View in: PubMed
    Score: 0.066
  18. Dominguez SR, Anderson MS, Glodé MP, Robinson CC, Holmes KV. Blinded case-control study of the relationship between human coronavirus NL63 and Kawasaki syndrome. J Infect Dis. 2006 Dec 15; 194(12):1697-701.
    View in: PubMed
    Score: 0.058
  19. Treadwell TA, Maddox RA, Holman RC, Belay ED, Shahriari A, Anderson MS, Burns J, Glodé MP, Hoffman RE, Schonberger LB. Investigation of Kawasaki syndrome risk factors in Colorado. Pediatr Infect Dis J. 2002 Oct; 21(10):976-8.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)